LIPO - LIPELLA PHARMACEUTICALS INC.
2.36
-0.345 -14.619%
Share volume: 310,975
Last Updated: 06-18-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$2.70
-0.35
-0.13%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | 03-27-2025 | 05-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 3.137 M | 2.184 M | 2.160 M | 2.674 M | 4.856 M | 2.350 M | |
| Current Assets | 3.011 M | 2.081 M | 2.080 M | 2.617 M | 4.823 M | 2.079 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 85.630 K | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.105 M | 1.187 M | 1.354 M | 2.185 M | 4.225 M | 1.856 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 12.029 K | 11.307 K | 10.585 K | 9.864 K | 9.142 K | 7.699 K | |
| Other Assets | 114.038 K | 91.978 K | 69.555 K | 46.754 K | 23.572 K | 262.823 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 3.137 M | 2.184 M | 2.160 M | 2.674 M | 4.856 M | 2.350 M | |
| Total liabilities | 575.878 K | 480.313 K | 701.186 K | 754.417 K | 776.847 K | 862.215 K | |
| Total current liabilities | 551.881 K | 480.313 K | 701.186 K | 754.417 K | 776.846 K | 642.399 K | |
| Accounts Payable | 293.835 K | 178.361 K | 459.453 K | 388.191 K | 392.115 K | 462.892 K | |
| Other liabilities | 23.997 K | 0.000 | 0.000 | 0.000 | 0.000 | 219.816 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 23.997 K | 0.000 | 0.000 | 0.000 | 0.000 | 219.816 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.561 M | 1.704 M | 1.459 M | 1.919 M | 4.079 M | 1.488 M | |
| Common stock | 14.077 M | 14.158 M | 15.357 M | 17.260 M | 20.726 M | 20.716 M | |
| Retained earnings | -11.516 M | -12.454 M | -13.898 M | -15.340 M | -16.647 M | -19.228 M |